We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Curis Inc | NASDAQ:CRIS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.15 | -0.91% | 16.36 | 14.77 | 16.96 | 16.78 | 16.05 | 16.78 | 10,608 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event Reported): December 9, 2020
Curis, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware | 000-30347 | 04-3505116 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
128 Spring Street, Building C - Suite 500, Lexington, MA 02421 |
(Address of Principal Executive Offices) (Zip Code) |
(617) 503-6500
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol |
Name of each exchange on which registered |
||
Common Stock, Par Value $0.01 per share | CRIS | Nasdaq Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. |
Other Events. |
On March 4, 2020, Curis, Inc. (the “Company”) entered into a Capital on DemandTM Sales Agreement (the “Sales Agreement”) with JonesTrading Institutional Services LLC, as agent (“JonesTrading”), pursuant to which the Company could offer and sell shares of its common stock, $0.01 par value per share (the “Common Stock”), from time to time through JonesTrading, as agent, under an “at-the-market” offering program for aggregate gross sale proceeds of up to $30,000,000 (the “ATM Offering”). The Company filed a prospectus supplement with the Securities and Exchange Commission on March 6, 2020 in connection with the ATM Offering (the “Prospectus Supplement”) under the Registration Statement.
The Company terminated the Sales Agreement effective as of December 9, 2020. The Company did not incur any termination penalties as a result of the termination of the Sales Agreement. As of the effective date of the termination of the Sales Agreement, the Company had sold an aggregate of 6,298,648 shares of its Common Stock pursuant to the Sales Agreement for aggregate gross proceeds of approximately $8.3 million and net proceeds to the Company of approximately $8.1 million, after deducting commissions and offering expenses payable by the Company. The approximately $21.7 million of Common Stock that had been available for sale pursuant to the Sales Agreement remained unsold at the time of its termination. The termination of the Sales Agreement terminated any future sales of Common Stock through the ATM Offering pursuant to the Prospectus Supplement.
A copy of the Sales Agreement was filed as Exhibit 1.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 6, 2020.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CURIS, INC. | ||||||
Date: December 9, 2020 | By: |
/s/ James E. Dentzer |
||||
Name: | James E. Dentzer | |||||
Title: | President and Chief Executive Officer |
1 Year Curis Chart |
1 Month Curis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions